Clinical trial
ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome
NCT00489333 · Health Enhancement Products, Inc., Industry · Completed
Key facts
| NCT number | NCT00489333 |
|---|---|
| Title | ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome |
| Official title | The Effects of ProAlgaZyme Novel Algae Infusion vs. Placebo on Metabolic Syndrome and Markers of Cardiovascular Health |
| Lead sponsor | Health Enhancement Products, Inc., Industry |
| Collaborators | University of Yaounde |
| Status | Completed |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X |
| Intervention type | Drug |
| Interventions | ProAlgaZyme |
| Enrollment | 52 |
| Start date | May 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jun 21, 2007 |
| Last update posted | Jun 21, 2007 |
| Countries | Cameroon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: